Primary health care policy and vision for community pharmacy and pharmacists in Australia by Benrimoj, Shalom Isaac et al.
Dineen-Griffin S, Benrimoj SI, Garcia-Cardenas V. Primary health care policy and vision for community pharmacy and 
pharmacists in Australia. Pharmacy Practice 2020 Apr-Jun;18(2):1967.  
https://doi.org/10.18549/PharmPract.2020.2.1967 
www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X) 1 
 
Abstract  
There is evidence that the Australian Government is embracing a more integrated approach to health, with implementation of 
initiatives like primary health networks (PHNs) and the Government’s Health Care Homes program. However, integration of 
community pharmacy into primary health care faces challenges, including the lack of realistic integration in PHNs, and in service and 
remuneration models from government. Ideally, coordinated multidisciplinary teams working collaboratively in the community setting 
are needed, where expanding skills are embraced rather than resisted. It appears that community pharmacy is not sufficiently 
represented at a local level. Current service remuneration models encourage a volume approach. While more complex services and 
clinical roles, with associated remuneration structures (such as, accredited pharmacists, pharmacists embedded in general practice and 
residential aged care facilities) promote follow up, collaboration and integration into primary health care, they potentially marginalize 
community pharmacies. Community pharmacists’ roles have evolved and are being recognized as the medication management experts 
of the health care team at a less complex level with the delivery of MedChecks, clinical interventions and medication adherence 
services. More recently, vaccination services have greatly expanded through community pharmacy. Policy documents from 
professional bodies highlight the need to extend pharmacy services and enhance integration within primary care. The Pharmaceutical 
Society of Australia’s Pharmacists in 2023 report envisages pharmacists practising to full scope, driving greater efficiencies in the 
health system. The Pharmacy Guild of Australia’s future vision identifies community pharmacy as health hubs facilitating the provision 
of cost-effective and integrated health care services to patients. In 2019, the Australian Government announced the development of a 
Primary Health Care 10-Year Plan which will guide resource allocation for primary health care in Australia. At the same time, the 
Government has committed to conclude negotiations on the 7th Community Pharmacy Agreement (7CPA) with a focus on allowing 
pharmacists to practice to full scope and pledges to strengthen the role of primary care by better supporting pharmacists as primary 
health care providers. The 7CPA and the Government’s 10-year plan will largely shape the practice and viability of community 
pharmacy. It is essential that both provide a philosophical direction and prioritize integration, remuneration and resources which 
recognize the professional contribution and competencies of community pharmacy and community pharmacists, the financial 
implications of service roles and the retention of medicines-supply roles. 
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AUSTRALIAN HEALTH CARE AT A GLANCE 
The Australian population was estimated to be 25.7 million 
in  May 2020.1 Australia is considered to have a world class 
health system. While Australians generally enjoy positive 
health outcomes, it is recognized the health system is 
under increasing strain from the rising rates of chronic 
illness and an ageing population.2,3 The clinical and 
economic burden represents a major challenge for the 
optimal provision of healthcare.4-6 The rapid change has 
resulted in major health system reform that is likely to 
continue over the coming years to improve patient access, 
enhance primary care, capitalize on technology, ensure a 
future-ready health workforce and deliver cost-effective 
health outcomes. 
Australia has a mixed-model of public and private health 
care, based on the principle of universal access. Australia’s 
health system is underpinned by Medicare, a universal 
public health insurance program which provides rebates 
against the cost of medical fees for Australians.2 This is 
funded partly by a Medicare levy on taxable income, with 
any shortfall being met by the government from general 
revenue.7 About 80% of general practitioner (GP) visits 
incur no patient out-of-pocket costs because the fee is paid 
directly by the government, while Australians are eligible to 
be treated in a public hospital without charge.2  
Australia’s health system is complex and is managed by all 
levels of Australian government including federal and state 
or territory.8 This complexity is reflected in its funding 
arrangements at all levels of government. Non-government 
organizations and private health insurers also provide 
funding while individuals pay out-of-pocket expenses for a 
number of products and services without full (or only 
partial) reimbursement. Spending on health has grown by 
50% (after adjusting for inflation) between 2006–2007 and 
2015–2016, from AUD 113 billion to AUD 170 billion. Total 
health spending was AUD 185.4 billion in 2017-2018 (or 
AUD 7,485 per person).9 Hospitals (40%) and primary 
health care (34%) accounted for three-quarters of total 
health spending.
9
 Governments funded the majority (AUD 
77.1 billion by the federal government; AUD 49.5 billion by 
state and territory governments) and non-government 
sources funded the remaining amount.9  
The federal government is responsible for leading the 
development of national health policy, subsidizing primary 
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health care services and providers through the Medicare 
Benefits Scheme (MBS), providing funds to states and 
territories for public hospital services, oversight of Primary 
Health Networks (PHNs), regulating private health 
insurance and funding medical research.8,10 Importantly, 
the federal government funds the national universal 
Pharmaceutical Benefits Scheme (PBS) providing timely and 
affordable access to prescription medicines at Government-
subsidized prices. Currently, the PBS patient co-payment is 
AUD 41 for general patients and AUD 6.60 for concessional 
patients per medicine, with thresholds in place for total 
patient contributions.11 Prescription medicines below these 
prices are paid in full by general patients. The federal 
government influences the cost of the PBS by determining 
which pharmaceuticals to list and negotiating the price with 
suppliers.8 The federal government funds community 
pharmacies to dispense and supply medicines under the 
PBS, alongside pharmacy services, an arrangement 
implemented through the Community Pharmacy 
Agreement (subject to renegotiation every five years).8 
State and territory governments are responsible for 
managing public hospital and Local Hospital Network (LHN) 
performance.10 The states are also responsible for funding 
and providing a range of community health services, 
including ambulance services, public dental care, and 
mental health care, with assistance from the federal 
government.10 
 
COMMUNITY PHARMACY IN AUSTRALIA 
The community pharmacy sector plays an important role in 
the Australian health care system.12 With the average 
Australian visiting a community pharmacy eighteen times a 
year, the sector provides accessible and timely care.13 
There were 32,412 registered pharmacists in December 
2019, and 5,797 community pharmacies in Australia.14,15 
Pharmacists are trained at university level, accredited by 
state or territory registration boards, and subject to federal 
and state or territory government regulations.14 The core 
role of the community pharmacist is dispensing medicines. 
This role couples clinical review of prescriptions, and 
professional activities such as counselling to ensure safe 
and effective use of medicines.16 The current scope of 
community pharmacy practice remains heavily dependent 
economically on the dispensing and provision of medicines.  
The ownership of community pharmacy is controlled at the 
state level, with the number of pharmacies owned by a 
single pharmacist being dependent on legislation. There are 
also location rules (i.e., for the establishment of a new 
pharmacy or relocation of an existing pharmacy) to supply 
PBS medicines.17 
 
POLICY CONTEXT IN AUSTRALIA 
National Medicines Policy 
Australia’s National Medicines Policy (NMP), implemented 
20 years ago, seeks to provide overarching policy direction 
around four key interlinked pillars including, timely access; 
medicines meeting standards of safety and efficacy; quality 
use of medicines (QUM); and maintaining a responsible and 
viable medicines industry.18,19 In 2019, the Federal Health 
Minister Greg Hunt MP announced a review of Australia’s 
NMP.20 Recommendations for the next iteration have 
emphasized measuring health outcomes that are valued 
and relevant to patients.20 
Medicines Safety: the 10th National Health priority area 
In November 2019, health ministers agreed to make 
medicines safety the 10th National Health priority area.21 
The Government responded to findings of both the Interim 
report of the Royal Commission into Aged Care, and the 
Pharmaceutical Society of Australia’s Medicine Safety: Take 
Care report.22-24 The latter report identified 250,000 
avoidable hospital admissions annually due to medication 
problems, and 400,000 emergency department 
presentations as a result of errors, inappropriate use, 
misadventure and drug interactions. At least half of these 
problems were considered preventable. Medicine 
misadventure costs Australia  AUD 1.4 billion annually.23  
Integrated primary health care 
Integrated care is a multifaceted concept often 
contraposed to fragmented or episodic care, and is used 
synonymously with terms like coordinated care and 
seamless care, among others.25,26 The Australian 
Government’s Productivity Commission released a report 
identifying issues with the Australian health system 
including the lack of integrated care, insufficient patient-
centered care, and a need to focus funding towards 
innovation or clinical and economic outcomes.27 The 
Strategic Framework for Integrating Care report in 2018 
sets a vision of integrated care in Australia.28 The drivers of 
this interest in integrated care are: optimized resource 
investment; coordination of care across different settings; 
reduced duplication of services; improved health of the 
population and; greater health literacy and self-care.28 
Federal and state or territory governments have 
progressed implementation to deliver integrated care in 
Australia.28 Multiple strategies are being employed 
including health reform and implementation of integrated 
service models.29-31 
Primary health networks – primary health care 
organisations 
A policy response was the establishment of a network of 
primary health care organisations, known as PHNs.32,33 
Thirty one PHNs were established across Australia, funded 
by AUD 900 million, replacing the 61 Medicare Locals 
previously operating.34 This network was created to 
operate at a regional level with the authority and 
accountability to plan, integrate and coordinate primary 
health care at a local level.35 PHNs work with primary care 
providers (primarily GPs), hospitals, and the broader 
community to: 
• increase the efficiency and effectiveness of medical 
services for patients, particularly those at risk of poor 
health outcomes, and; 
• improve coordination of care to ensure patients receive 
the right care in the right place at the right time.36 
Each PHN conducts a local needs assessment to identify 
health and service needs within their regions and prioritizes 
activities (and funding) to address those needs.37 
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The 10-year Primary Health Care Plan 
The Australian Government appointed a primary health 
care reform steering group in 2019 to provide independent 
advice for the development of the 10-year Primary Health 
Care Plan. The steering group consists of representatives 
from professions including general practice, nursing, 
speech pathology and physiotherapy professions, with no 
representation from community pharmacy.3 The plan will 
guide primary health care resource allocation in Australia 
(AUD 104 billion into the health system from 2019–2020 
and a total of AUD 435 billion over four years). It also aims 
to guide future primary health care reform for further 
integration as part of the Government’s Long-Term 
National Health Plan.3 
The Long-Term National Health Plan includes: 
• The 2030 mental health vision; 
• The 10-year Primary Health Care Plan; 
• Continued improvement of private health insurance; 
• The 10-year National Preventive Health Strategy, and; 
• The 10-year Medical Research Future Fund investment 
plan.3 
In the Government’s 10-year Primary Health Care Plan, the 
Government committed to concluding negotiations on the 
next community pharmacy agreement (“The seventh 
agreement or 7CPA”) focusing on pharmacists practicing to 
their full scope.3 It also pledged to better support 
pharmacists in their roles as primary health care providers.3 
 
INTEGRATION OF COMMUNITY PHARMACY IN 
THE BROADER HEALTH SYSTEM 
Governments are embracing a more integrated approach to 
health, with implementation of primary care initiatives like 
PHNs and the Government’s Health Care Homes 
program.32,33,38 However, the integration of community 
pharmacy into primary health care faces challenges, 
including the lack of realistic integration in PHNs, and in 
service and remuneration models from government. 
Ideally, coordinated multidisciplinary teams working 
collaboratively in the community setting are needed, where 
expanding skills are embraced rather than resisted. 
Community pharmacists need be included in PHNs’ 
governance, decision making and advisory structures, as it 
appears they are not sufficiently represented at this local 
level. 
Recent pharmacy policy documents from professional 
bodies highlight the need to extend community pharmacy 
services and enhance integration within primary health 
care. The Pharmaceutical Society of Australia has 
developed the strategic document Pharmacists in 2023 
which envisages pharmacists practising to full scope and 
driving greater efficiencies in the health system.16 The 
report outlines eleven changes to deliver QUM by better 
utilizing pharmacists in the future.16 Key themes such as 
pharmacists being the ‘custodians’ of medication safety 
and their role in digital health (including My Health Record, 
an online platform with patient health information imputed 
by healthcare providers across the sector), were outlined. 
The Pharmacy Guild of Australia’s Community Pharmacy 
2025 outlines the organizations strategic vision for viability 
and the future of community pharmacy as an integral part 
of the Australian health care system. The report identifies 
pharmacy as health hubs facilitating the provision of cost-
effective and “integrated” services to patients.39,40 The 
report was informed by qualitative and quantitative market 
research, subject experts and a strategic advisory firm.41  
A significant barrier to pharmacists achieving high-impact 
contribution as integrated members of the health team is 
the current state of remuneration for services. The right 
incentives must be provided for all health practitioners, like 
GPs, nurses and pharmacists to integrate services 
effectively, with clear responsibilities contributing to 
overall health outcomes. The Pharmaceutical Society 
recommends funding that reflects quality and complexity of 
pharmacist care.16 This may be achieved through 
establishing practice incentive payments linked to quality 
measures, revising remuneration structures to account for 
complexity, or moving to a time-based fee structure.16 All 
aspects of the pharmacist’s role need to be resourced 
appropriately. However, there will also be specific 
challenges such as freeing pharmacists’ time to deliver 
services, recording and using data to demonstrate value for 
the viability of community pharmacy. Without adequate 
funding and recognition of pharmacist’s contributions to 
primary care, it will be difficult to ensure integration. 
In the Australian Government’s Response to the Review of 
Pharmacy Remuneration and Regulation, the government 
recognised the pivotal role of the community pharmacy 
sector.
42
 The government states that it is committed to 
working closely with community pharmacies and other 
stakeholders to address the significant pressures being 
placed on the health care system. As highlighted in the 
report Bankwest Future of Business: Focus on Pharmacy, 
the community pharmacy sector is positioned to expand 
the services available and establish themselves as local 
healthcare centres, further reducing the demand on 
hospitals and other primary health care facilities.13,43  
The Community Pharmacy Agreement 
The primary driver of pharmacy policy and direction from a 
governmental perspective are five year agreements 
negotiated between the federal government and the 
Pharmacy Guild of Australia, with some influence and 
representation by the Pharmaceutical Society of 
Australia.44,45 The agreement sets out the remuneration 
associated with dispensing prescription medications and 
services, which in turn, determines scope of practice and 
roles for community pharmacy.46 The current agreement 
(“the sixth agreement or 6CPA”) is due to expire on June 
30th 2020. The 6CPA includes three key funding elements, 
namely: 
• Community pharmacy remuneration; 
• The Community Services Obligation funding pool; 
• Community pharmacy programs.47-50 
It was originally estimated that AUD 18.9 billion was to 
fund community pharmacy over five years, comprising AUD 
15.5 billion from the government and AUD 3.4 billion from 
PBS co-payments paid by patients.51 In addition, the 2017-
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2018 budget included AUD 225 million in payments to 
community pharmacies over the remaining life of the sixth 
agreement to compensate for lower than forecast PBS 
prescription volumes.52 A number of other programs have 
been funded throughout the life of the 6CPA. 
 
PHARMACY PROGRAMS AND SERVICES 
Australian pharmacists have long provided services to 
patients.13,53-57 The 2018 Pharmacy Barometer report 
indicated that 19% of community pharmacy owners (one-
fifth) employ a pharmacist solely dedicated to the provision 
of pharmacy services.58 Services can be divided into those 
funded by the 6CPA, and services with other sources of 
funding (i.e., PHNs, or services paid for by the patient) 
(Table 1).  
A total of up to AUD 1.26 billion in funding was available for 
pharmacy programs and services under the 6CPA.50 This 
consisted of: 
• AUD 613 million for the continuation of a number of 
programs and services from the 5CPA;  
• AUD 50 million for a new pharmacy trial program (PTP); 
and  
• up to AUD 600 million for new and expanded community 
pharmacy programs.  
The 6CPA encompasses a number of areas of practice 
including: Medication adherence programs, Medication 
management programs, and other trial programs. 
Medication adherence programs 
Dose administration aids: (a well-sealed that allows 
individual medicine doses to be organized according to the 
prescribed dose schedule).59 Incentives are divided among 
the number of claiming pharmacies on a pro rata basis for 
the activity documented. In 2016, the average claim 
amount earned by pharmacies, per dose administration aid, 
was AUD 3.84.60 
Staged supply (medicines provided by the community 
pharmacy in instalments to patients). The service is of 
particular value to patients with a mental illness, drug 
dependency, or who are unable to manage their medicines 
safely (eg. people living in accommodation where there is 
the possibility of theft or lack of refrigeration). Pharmacies 
may claim payments for up to 15 patients per month. For 
the provision of the first staged supply, a pharmacy may 
claim a fee of AUD 8.12 per patient. For each subsequent 
supply during the same week period, the pharmacy may 
claim a fee of AUD 4.12 per patient.  
Clinical interventions (a documented clinical activity 
contributing to improved medicines utilization, QUM, or 
reduced adverse outcomes). Reimbursement is based on 
the number of interventions within a defined period of 
time per pharmacy. Payment is subject to a cap of 3.5% of 
prescription volume for individual pharmacies.61 Incentives 
are divided among the number of claiming pharmacies on a 
pro rata basis for the activity documented. In 2016, the 
average amount remunerated per intervention was AUD 
3.40.60 
Medication management programs 
MedsCheck and Diabetes MedsCheck: (an in-pharmacy 
medicines review service between the patient and 
community pharmacist to improve QUM and patient 
outcomes). A diabetes MedsCheck builds on the format of a 
MedsCheck service focusing specifically on patient’s with 
type 2 diabetes. Pharmacies are subject to a combined 
service cap of twenty MedsChecks or diabetes MedsChecks 
per month. The community pharmacy is remunerated a fee 
of AUD 66.53 per patient for a MedsCheck, or AUD 99.79 
for a diabetes MedsCheck.62  
Home Medicines Reviews (HMR): (a medicine review 
provided by an accredited pharmacist in the patient’s 
home, following referral by a medical practitioner). 
Following interview with the patient, the accredited 
pharmacist produces a report detailing recommendations 
to assist the referrer and patient in developing a 
medication management plan. Only accredited pharmacists 
who have undertaken additional training and assessment 
are authorized to provide medicine review services. To 
maintain accreditation status, pharmacists must complete 
20 additional continuing professional development (CPD) 
credits annually (in addition to the 40 CPD credits required 
for general registration).63  
Changes announced in April 2020 are the most significant 
since the program’s inception, providing a unique 
opportunity for accredited pharmacists to have a greater 
role in the health system. Pathways available for HMRs 
have been broadened to include referrals from medical 
practitioners other than GPs. Pharmacists may also initiate 
up to two remunerated follow-up services within nine 
months of the initial interview.64 Pharmacies and 
accredited pharmacists are subject to a cap of 30 HMRs per 
month. A fee of AUD 222.77 per patient may be claimed for 
the initial HMR service (interview and report), while an 
additional AUD 111.39 and AUD 55.70 may be claimed for 
the provision of first and second follow-up services, 
respectively.64 
Residential Medication Management Reviews (RMMR) and 
QUM: (to enhance the QUM in residential aged care 
facilities). An RMMR is a service provided to a permanent 
resident of a residential aged care facility by an accredited 
pharmacist. It involves a comprehensive assessment to 
identify and resolve medicine-related problems. The QUM 
service is a separate service provided by a registered or 
accredited pharmacist focusing on improving practices and 
procedures as they relate to quality and safe use of 
medicines in a residential care facility.65 
The above services form the core of the remuneration 
associated with the delivery of services funded by the 
federal government. Most, if not all, of this funding is 
claimed by community pharmacies indicating that most are 
taking advantage of this remuneration. However, this still 
forms a relatively small percentage of the total revenue for 
a community pharmacy. 
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Table 1. Pharmacy programs and services 
Services funded under the 6CPA  Medication management programs 
o MedsCheck and Diabetes MedsCheck  
o Home Medicine Reviews  
o Residential Medication Management Reviews and Quality Use of Medicines 
 Medication adherence programs 
o Clinical Interventions 
o Dose administation aids 
o Staged Supply 
Other funded programs under the 
6CPA 
 Trial programs 
o Community Pharmacy in Health Care Homes trial  
o Take Home Naloxone pilot trial 
o Pharmacy Trial Programs 
 Pharmacy Diabetes Screening trial 
 Indigenous Medication Review Service feasibility (IMeRSe) trial 
 Getting Asthma Under Control (PTP-ARC) trial 
 Integrating practice pharmacists into Aboriginal Community Controlled Health 
Services (the IPAC project) 
 Reducing Medicine Induced Deterioration and Adverse Reactions (ReMInDAR) trial 
 Early detection and management of cardiovascular disease risk factors (CVD) trial 
 Chronic Pain MedsCheck trial 
 Mental Health service (PharMIbridge) trial 
 Other programs 
o eHealth programs 
 Electronic Prescription Fee 
o Rural support programs 
 Rural Pharmacy Workforce Program  
 Rural Pharmacy Maintenance Allowance 
o Aboriginal and Torres Strait Islander (ATSI) specific programs 
 Quality Use of Medicines Maximized for ATSI People (QUMAX)  
 S100 Pharmacy Support Allowance 
 ATSI Workforce Program (Pharmacy Assistant Traineeship Scheme and Pharmacy 
Scholarships Scheme) 
Services with other sources of 
remuneration (ie. through PHNs 
or the Workforce Incentive 
Program) 
 General practice pharmacists 
Unremunerated services or a fee 
paid by patients 
 Immunisation services 
 Chronic disease management support 
o Blood pressure monitoring 
o Cholesterol monitoring 
o Blood glucose monitoring 
o Inhaler technique checks 
o INR recording 
o HbA1c monitoring 
 Health checks to support early detection 
o COPD screening 
o Australian Type 2 Diabetes risk assessment (AUSDRISK™) 
o Obstructive sleep apnoea screening 
 Health promotion services 
o Weight management 
o Smoking cessation 
 Emergency contraception 
 Wound care services 
 Compounding services 
 Staged supply services 
 Mental health support services 
 Needle and syringe exchange services 
 Opioid substitution therapy services 
 Return of unwanred medicines 
 Baby progress recording 
 Breastfeeding advice and support 
Future services  Minor ailment service 
 Pharmacist prescribing 
o Urinary tract infection prescribing trial 
 Continued dispensing 
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Additional programs 
Community Pharmacy in Health Care Homes trial: (an 
initiative funded to support the incorporation of 
medication management programs within Health Care 
Homes). A Health Care Home is a general practice (or 
Aboriginal Community Controlled Health Service) that 
coordinates care for patients with chronic and complex 
conditions.38 Pharmacies involved in the trial work in 
conjunction with the Health Care Home team by delivering 
patient-centred medication management services until the 
trial concludes on June 30th 2021. Community pharmacy’s 
role in Health Care Homes is to conduct an initial 
medication reconciliation of a patient’s medicines, and 
develop a Medication Management Plan. The plan includes 
(1) goals of medication therapy (i.e., proposed plan of 
action), (2) person responsible for the identified goal (eg. 
patient, pharmacist, or GP), (3) identification of medication 
adherence and management services (e.g., blood pressure 
monitoring, blood glucose monitoring, dose administration 
aids, or development of an asthma action plan), (4) 
reconciled medication list, and (5) proposed review date. 
Each patient is assigned to a complexity tier and 
pharmacies are remunerated accordingly (Table 2).66,67 
However, there appears to be no publicly available data on 
the uptake of the program.  
Take Home Naloxone pilot trial: Under this trial, naloxone is 
available to people at risk of overdose, which includes illicit 
drug users and people who use prescription opioids, or 
their carers/ family at no-charge. No prescription is 
required. The Australian government has invested AUD 10 
million in the pilot, running between December 1
st
 2019 
and February 28th 2021. Payments are made for each 
individual supply of naloxone ranging from AUD 41.34 to 
AUD 48.42 (excluding GST) depending on the product 
supplied.68 
Pharmacy Trial Programs 
As aforementioned, AUD 50 million was allocated to 
support PTP programs under the 6CPA. The PTP was 
introduced to trial new or expanded community pharmacy 
programs with the aim of improving clinical outcomes for 
patients and extending the role of community 
pharmacists.69,70 As follows: 
Pharmacy Diabetes Screening trial: The trial aimed to 
compare clinical and cost effectiveness of three different 
pharmacy-based diabetes screening interventions 
(including AUSDRISK™ assessment) for early detection, 
education and referral.71,72  
Indigenous Medication Review Service feasibility (IMeRSe) 
trial: The trial aimed to optimize patient's medication 
management via a culturally responsive service for 
Indigenous Australians, delivered by community 
pharmacists integrated with Aboriginal Community 
Controlled Health Services.73 
Getting Asthma Under Control (PTP-ARC) trial: The trial 
aimed to improve clinical outcomes for populations at risk 
of uncontrolled asthma. The intervention targeted three 
factors associated with uncontrolled asthma including 
adherence, suboptimal inhaler technique or uncontrolled 
allergic rhinitis.74  
Integrating practice pharmacists into Aboriginal Community 
Controlled Health Services (the IPAC project): The trial 
aimed to evaluate the impact of pharmacists in Aboriginal 
health settings providing medication management services 
to ATSI people. Ten full time equivalent pharmacists 
integrated into Aboriginal Community Controlled Health 
Service sites were conducting patient-related and practice-
related activities.75 
Reducing Medicine Induced Deterioration and Adverse 
Reactions (ReMInDAR) trial: The trial aimed to determine 
the effectiveness of a pharmacist service in reducing 
medicine-induced deterioration, frailty and adverse 
reactions in older people living in aged-care facilities.76 
Early detection and management of cardiovascular disease 
risk factors (CVD) trial: The trial aimed to evaluate health 
checks to detect, diagnose and enable early intervention of 
cardiovascular disease. The service was delivered by 
community pharmacists in collaboration with general 
practice and other providers to ensure individuals with 
elevated risk status were offered appropriate treatment to 
reduce their overall risk and improve quality of care.77  
Chronic Pain MedsCheck trial: The trial aimed to assist 
patients taking medication for ongoing chronic pain. The 
service involved a consultation with a pharmacist to review 
pain medication use and develop an action plan, 
incorporating education, self-management and/or referral 
where required.78 
Bridging the Gap between Physical and Mental Illness in 
Community Pharmacy (PharMIbridge) trial: The primary 
focus of this AUD 5 million trial is on medication adherence 
and improving quality of life for mental health patients.79 
The trial, planned to start later this year (2020), will involve 
35 pharmacies across three states and territories.80  
Services with other sources of remuneration 
General practice pharmacists’: In recent years there has 
been an increase in pharmacists working in general practice 
in Australia, with evidence showing that pharmacists 
provide valuable support to the general practice team.81 
Table 2. Payments for the provision of Health Care Homes medication management services for community pharmacies 
Tier Category 
Total per patient 
capped payment trial period 
Inclusions 
Tier 1 (Multiple chronic conditions) AUD 418.75 Initial Medication Management Plan; three follow up 
reviews; health outcome data collection. 
Tier 2 (Multimorbidity and moderate needs) AUD 1,372.75 Initial Medication Management Plan; three follow up 
reviews; health outcome data collection; supporting 
services (flexible category). 
Tier 3 (High risk chronic and complex needs) AUD 1,642.75 Initial Medication Management Plan; three follow up 
reviews; health outcome data collection; supporting 
services (flexible category). 
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Several PHNs provide or have provided funding to embed 
non-dispensing pharmacists in general practice in defined 
regions.82-84 In February 2020, the Workforce Incentive 
Program funding stream commenced providing general 
practices with financial support to employ nurses, 
Aboriginal and Torres Strait Islander practitioners, allied 
health professionals, and pharmacists in rural and remote 
areas. Pharmacists are included in this list for the first time, 
which means the opportunity exists for general practices to 
use this funding to support the employment of 
pharmacists.81,85  
General practice pharmacists perform a range of clinical 
and administrative duties related to their expertise in 
medication use and safety.86 The services provided by 
pharmacists in general practice varies between practices, 
but generally includes: 
• Patient-focused activities including resolving medicines 
use and safety problems, medicines education, medicines 
reconciliation or improving relationships with other 
providers including community pharmacists; 
• Staff-focused activities including practice staff education 
sessions and answering medication information queries; 
• Practice-based activities including Drug Utilisation 
Reviews (criteria-based evaluation of drug use to help 
ensure medicines are used appropriately at the individual 
patient level) and advice on prescribing according to 
evidence-based guidelines.82 
General practice pharmacists provide an opportunity to 
improve collaborative working relationships between GPs 
and community pharmacists and provide a link to existing 
community pharmacy services.87  
Unremunerated services or a service fee paid by patients 
Vaccination services: (community pharmacists deliver a 
range of vaccinations, primarily influenza, depending on 
state and territory-based legislation). Community 
pharmacists have rapidly adopted broader roles in 
providing immunization services since 2014, in all states 
and territories since 2016, leading to increased vaccination 
rates.88,89 A pharmacist with general registration may 
administer vaccinations after completing an approved 
course of training, cardiopulmonary resuscitation, and first 
aid including anaphylaxis training, and are permitted under 
state or territory legislation.88,90  
In all jurisdictions across Australia, trained pharmacists can 
legally administer vaccinations, but the range of 
vaccinations and the allowable age of patients varies by 
jurisdiction. Each state and territory have differing 
vaccination legislation, regulations and training 
requirements. For example, under New South Wales 
regulation and authorization, pharmacists can administer 
diphtheria-tetanus-pertussis (whooping cough) (dTpa) and 
measles-mumps-rubella (MMR) vaccines to people aged 16 
years and over and privately funded influenza vaccines to 
people aged 10 years and over.91 The Queensland 
Government in February 2020 lowered the age that 
approved pharmacists to administer the influenza vaccine 
to people aged 10 years and above, and expanded the 
range of vaccines (available to persons 16 years and above) 
to include: dTpa, dTpa in combination with inactivated 
poliovirus, poliomyelitis, MMR, cholera, hepatitis A, 
haemophilus influenzae type B, meningococcal ACWY and 
pneumococcal vaccine.92 
Currently, trained pharmacists in Victoria, Western 
Australia and the Australian Capital Territory (but not all 
states and territories) can administer government-funded 
vaccines to eligible persons under the National 
Immunisation Program (NIP).92,93 The NIP provides vaccines 
to eligible people at no charge to the patient. The influenza 
vaccine is available free-of charge under the NIP for people 
in at risk groups (ie. all people aged 6 months to 5 years 
(this cohort is newly eligible in 2020), Aboriginal and Torres 
Strait Islander people aged 6 months and over, people aged 
65 years and over, pregnant women, and people aged six 
months and over with medical conditions that increase risk 
of influenza complications).94 There have been calls for a 
nationally consistent approach and to extend the NIP to 
allow pharmacists in all states and territories to administer 
vaccinations under the program.95,96 With wide public 
acceptance, and the fact that some consumers are willing 
to pay for the service even if eligible to receive a 
vaccination at no cost at their general practice, underpins 
the need to have these vaccinations easily accessible to 
ensure greater uptake through all community pharmacies.  
Future services 
Minor ailment service: Non-prescription medicines are 
divided into two scheduling categories in Australia: 
Schedule 2 medicines (“pharmacy medicines”) provided 
under supervision of a pharmacist and Schedule 3 
medicines (“pharmacist only medicines”) handed out by 
the pharmacist directly. A trial undertaken in 2018 
evaluated a community pharmacist delivered minor 
ailment service to triage, manage and appropriately refer 
patients to GPs through agreed pathways. The rationale of 
the trial was to support community pharmacy integration, 
standardize practice, and increase the quality and safe use 
of nonprescription medicines.57,97,98  
Pharmacist prescribing: Pharmacist prescribing of Schedule 
4 and 8 medicines (“prescription only medicines”) is not 
currently permitted. Health professionals who have 
prescribing rights in Australia, other than medical doctors, 
include dentists, optometrists, midwives and nurse 
practitioners.99 There has been much discussion about 
expanding prescribing rights to pharmacists. In a position 
statement released by the Pharmacy Board of Australia in 
2019, the Pharmacy Board concluded that under Australian 
law there are no regulatory barriers to collaborative 
prescribing which is undertaken alongside medical 
professionals, or under structured arrangements where 
pharmacists have limited authorization to prescribe under a 
guideline or standing order.100,101 Legislative, regulatory 
and practice changes are required to allow pharmacists to 
collaboratively prescribe within health teams under these 
models. Autonomous prescribing would require additional 
regulation and would need to be signed off by state and 
federal governments.101 
Urinary tract infection prescribing trial: Community 
pharmacists in Queensland will be involved in a urinary 
tract infection (UTI) prescribing trial, expected to launch 
mid-2020.102 The aim of the trial is for community 
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pharmacists to provide optimal care to women with 
uncomplicated UTIs.102 The rationale of the service is to 
improve access to care and reduce visits to emergency 
departments and other health providers.102 
Continued dispensing: More recently, the Australian 
Government approved a number of temporary dispensing 
changes in response to the widespread bushfires and the 
COVID-19 pandemic.103 Under strict conditions, 
pharmacists are able to supply PBS medicines to patients in 
emergency situations.104 A patient may receive one supply 
of their usual medicine without a prescription in a 12-
month period at the usual PBS consumer co-payment.103 
Continued dispensing arrangements are in place until June 
30th 2020.103 
 
FUTURE DIRECTIONS FOR COMMUNITY 
PHARMACY 
Future directions for community pharmacy and 
pharmacists will be influenced both by economic and 
professional factors.46 The national agreement is thought to 
be a blueprint for professional services and sets out the 
remunerated roles for community pharmacy. Thus, the 
next agreement (7CPA) and the Government’s 10-year 
Primary Health Care plan will become the determinant of 
sustainability for the profession.46 It is clear that the next 
five years will be critical to lay the foundation for change 
that is needed to support further integration of community 
pharmacy into primary care. Policy and funding support 
must be included for services that complement and expand 
integrated models and promote access to services led by or 
are conducted in collaboration with pharmacists. Generally, 
more complex services and clinical roles and their 
associated remuneration structures (such as, accredited 
pharmacists, pharmacists embedded in general practice 
and residential aged care facilities) promote integration 
into primary care and follow up. However, this has the 
potential to marginalize community pharmacies. 
Nevertheless, community pharmacists’ roles have evolved 
and pharmacists are being recognized as the medication 
experts of the health team. Vaccination services have 
greatly expanded through community pharmacies and are 
considered to be highly successful, reflecting the reach and 
accessibility of the pharmacy network. The challenge for 
the future in Australia will be determining which 
professional services are envisaged by payers to be 
delivered via the community pharmacy structure, and 
which services will be delivered by other types of 
pharmacists, not linked nor employed by community 
pharmacies. Interestingly, there is endorsement from 
consumer associations such as Consumers Health Forum of 
Australia. Leanne Wells, Chief Executive of the Consumers 
Health Forum of Australia in ‘The future of pharmacy is in 
the primary care sector’ highlights the need for care to be 
better coordinated and delivered by a cohesive team 
comprising a GP, nurse and a pharmacist at a minimum 
with appropriate care from others as needed.105 In 
addition, the 2018 Pharmacy Barometer survey of 361 
Australian pharmacists showed that community 
pharmacists reported ‘very good’ working relationships 
with GPs, and the majority identified that their opinion and 
expertise is well respected.58 
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